Nicholas Pension Consultants
Plumbers Local Union No. 1 Benefit Funds
Retirement Plan Consultants
Farmer & Betts, Inc.
EPIC Retirement Plan Services
Loren D. Stark Company
Pension Rights Center
Pension Plan Specialists
RTD Financial Advisors
Kentucky Trust Company
Retirement Industry Trust Association (RITA)
Hochheiser Deutsch & Co, Inc.
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|The Impact of New Hepatitis C Drugs on National Health Spending|
Dec. 8, 2015
"[T]he huge jump in prescription drug spending that occurred in 2014 was unforeseen. In 2013, spending on prescription drugs grew by only 2.4 percent, but in 2014, it skyrocketed to 12.2 percent. Some of this increase in spending on prescription drugs is due to expanded coverage, and some is due to the acceleration in prescription drug prices. A major source of this growth was the introduction of Sovaldi in December 2013, and Harvoni in October 2014.... U.S. sales of hepatitis C drugs seem to have stabilized at about $14 billion per year, which equates to about 150,000 persons treated per year (at a rate of $90,000 per person treated)."
|Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above).|
|An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified).|